Abstract
Neuronostatin is a recently described neuropeptide that is derived from the somatostatin preprohormone. We have shown previously that neuronostatin led to a biphasic, dose-related increase in mean arterial pressure when injected into the lateral cerebroventricle of adult, male rats. Because neuronostatin depolarized both magnocellular and parvocellular, paraventricular nucleus neurons in hypothalamic slice preparations, we hypothesized that neuronostatin elevated mean arterial pressure first by stimulating sympathetic nervous system activity followed by the release of a pressor hormone, specifically vasopressin. We found that the first phase of neuronostatin-induced increase in mean arterial pressure was reversed by pretreatment with phentolamine, indicating that phase 1 was, indeed, due to an increase in sympathetic activity. We also found that centrally injected neuronostatin led to a dose-related increase in vasopressin secretion in a time course consistent with the peak of the second phase. Furthermore, the second phase of arterial pressure elevation was reversed by pretreatment with a vasopressin 1 receptor antagonist, indicating that phase 2 was likely due to an increase in vasopressin secretion. We previously have shown that the anorexigenic and antidipsogenic effects of neuronostatin were reversed by pretreatment with the melanocortin 3/4 receptor antagonist, SHU9119, so we evaluated the ability of SHU9119 to reverse the effects of neuronostatin on MAP and vasopressin secretion. We found that SHU9119 abrogated the second phase of neuronostatin-induced increase in MAP and neuronostatin-induced vasopressin secretion, indicating that neuronostatin acts through the central melanocortin system to increase vasopressin release, ultimately leading to an elevation in MAP. © 2011 the American Physiological Society.
Recommended Citation
G. L. Yosten et al., "Neuronostatin acts in Brain to Biphasically Increase Mean Arterial Pressure Through Sympatho-activation Followed by Vasopressin Secretion: The Role of Melanocortin Receptors," American Journal of Physiology Regulatory Integrative and Comparative Physiology, vol. 300, no. 5, pp. R1194 - R1199, American Physiological Society, May 2011.
The definitive version is available at https://doi.org/10.1152/ajpregu.00849.2010
Department(s)
Biological Sciences
Publication Status
Open Access
Keywords and Phrases
Blood pressure; Melanocortins; Vasopressin
International Standard Serial Number (ISSN)
1522-1490; 0363-6119
Document Type
Article - Journal
Document Version
Final Version
File Type
text
Language(s)
English
Rights
© 2025 American Physiological Society, All rights reserved.
Creative Commons Licensing

This work is licensed under a Creative Commons Attribution 4.0 License.
Publication Date
01 May 2011
PubMed ID
21325646
Neuronostatin Acts In Brain To Biphasically Increase Mean Arterial Pressure Through______Sup2.pdf (1502 kB)
Neuronostatin Acts In Brain To Biphasically Increase Mean Arterial Pressure Through______Sup3.pdf (1485 kB)
Neuronostatin Acts In Brain To Biphasically Increase Mean Arterial Pressure Through______Sup4.pdf (1577 kB)
Neuronostatin Acts In Brain To Biphasically Increase Mean Arterial Pressure Through______Sup5.pdf (1574 kB)
Neuronostatin Acts In Brain To Biphasically Increase Mean Arterial Pressure Through______Sup6.pdf (31 kB)

Comments
National Institute of General Medical Sciences, Grant T32GM008306